Hospital groups urge HRSA to institute 340B final rule

The Health Resources and Services Administration is considering another delay of a final rule that would set price ceilings in the 340B drug discount program, but hospital organizations are urging the agency to finalize the price caps now. HRSA issued a proposed rule (PDF) earlier this month that would delay to July 2019 regulations that would set the ceiling price and impose civil penalties on drug companies that knowingly charge 340B hospitals above that price cap. The delay, if it goes through, would be the fifth time the agency has pushed back the rule.